A Study of Galcanezumab in Healthy Participants
Clinical trial NCT02576951 · COMPLETED
Trial details
- NCT number
- NCT02576951
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-19
- Primary completion
- 2016-09-03
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.